skip to Main Content

Pancreatic Cancer Trial to Make Tumors More Sensitive to Treatment

Newsfeed image, light gray text on dark gray background

Cancer Research UK launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy.

The trial, which launches in the UK today, will treat pancreatic cancer patients whose cancer has grown too big to be removed by surgery but has not yet spread to other parts of the body.

The team will give patients on the trial a drug called olaparib, in addition to the standard treatment of chemotherapy and radiation known as chemoradiation. Cancer Research UK support helped to develop this drug. Read more . . .

Back To Top